According to GlobalData’s medical device pipeline database, 22 Gynecological Devices devices are in various stages of development globally. GlobalData’s report Gynecological Devices provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Of these devices, 13 are in active development, while the remaining nine are in an inactive stage of development. There are ten products in the early stages of development, and the remaining three are in the late stages of development.
This includes Endometrial Ablation Devices and Female Sterilization Devices.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Gynecological Devices pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Gynecological Devices devices. Overall, most of these Gynecological Devices pipeline devices are being developed by private entities.
Key players involved in the active development of Gynecological Devices include Acoustic MedSystems, BioProtect, Collamedix, Coloplast, CooperSurgical, Feminora, FemTherapeutics, Global Health Partnerships, Memorial Sloan Kettering Cancer Center and Mirabilis Medical.
For a complete picture of the developmental pipeline for Gynecological Devices devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.